← Human Trials & Peer-Reviewed Studies
Cervicovaginal zinc and copper profiles across vaginitis phenotypes and hydrogel assignment: an exploratory pilot study.
Plain-language guide to PMID 42947086 (2026): pilot randomized controlled trial of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in 56 women.
Key Facts
- PMID
- 42947086
- Journal
- BMC women's health
- Year
- 2026
- Study type
- Randomized Controlled Trial
- Authors
- Kunkli A et al. (10 authors)
- DOI
- 10.1186/s12905-026-04768-6
- Registered trial
- NCT05895162
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement), published as a randomized controlled trial.
Zinc (Zn) and copper (Cu) support epithelial integrity, nutritional immunity, and host-microbiome interactions, yet cervicovaginal trace-metal dynamics across vaginitis phenotypes remain poorly defined.
The researchers prospectively quantified cervicovaginal lavage (CVL) Zn and Cu by ICP-OES in an exploratory secondary analysis nested within a single-center randomized trial involving 56 symptomatic women and asymptomatic controls (mean age, 36.0 ± 11.8 years; mean BMI, 23.1 ± 4.9 kg/m²).
Who Took Part
The study group was 56 women.
The age groups tagged for this paper are adults and middle-aged adults, women only.
How the Study Was Run
The researchers set it up as a randomized and pilot study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.
What Was Measured
The researchers prospectively quantified cervicovaginal lavage (CVL) Zn and Cu by ICP-OES in an exploratory secondary analysis nested within a single-center randomized trial involving 56 symptomatic women and asymptomatic controls (mean age, 36.0 ± 11.8 years; mean BMI, 23.1 ± 4.9 kg/m²).
Topics PubMed links to this paper include Pilot Projects, Zinc, Copper, Phenotype, Cervix Uteri, Candida albicans and Vagina.
Author keywords: Cervicovaginal lavage, Functional hydrogel, Vulvovaginitis and Zinc-containing hydrogel.
What This Means in Plain Language
The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in 56 women.
The publication is from 2026 (BMC women's health), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, all human trials.
Our Notes on the Compounds
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.